Skip to main content
Premium Trial:

Request an Annual Quote

NIAID to Fund Consortium for Rapid HIV MDx Test

NEW YORK (GenomeWeb News) — The National Institute of Allergy and Infectious Diseases expects to fund two reimbursement contracts for a period of five years, beginning next August, to support a consortium of scientists in developing a molecular diagnostic test for HIV.
The test will be a simple and rapid point-of-care diagnostic device that could be used in clinics that do not have lab equipment, such as pipettes and centrifuges, and which would require limited sample manipulation. NIAID said the test should generate results in a visual format with no ambiguity in the results.
Responses to the request for proposals are due by Dec. 2.
More information about the request may be found here.